Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: A subgroup analysis of the RE-LY trial
View Publication
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation (A Randomized Evaluation of Long-term Anticoagulation Therapy Trial Analysis)
View Publication
Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation (A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy)
View Publication
Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS2 Score
View Publication
Dabigatran Versus Warfarin (Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation)
View Publication
Stroke prevention in AF: Of Asians and non-Asians
View Publication